The effect of medication reviews on reducing medication anticholinergic burden in elderly patients

Abed, Howraa; Morrissey, Hana; Ball, Patrick

dc.contributor.author	Abed, Howraa
dc.contributor.author	Morrissey, Hana
dc.contributor.author	Ball, Patrick
dc.date.accessioned	2017-11-28T15:31:29Z
dc.date.available	2017-11-28T15:31:29Z
dc.date.issued	2017-11-30
dc.identifier.citation	Abed, H., Morrissey, H., Ball, P. 'The effect of medication reviews on reducing medication anticholinergic burden in elderly patients', International Journal of Recent Advances in Multidisciplinary Research, 4 (11) pp. 3060-3065
dc.identifier.issn	2350-0743
dc.identifier.uri	http://hdl.handle.net/2436/620910
dc.description.abstract	Anticholinergic side effects of medications often misdiagnosed as cognitive function decline in the elderly. The study aims to explore the effectiveness of home medication reviews on reducing anticholinergic burden caused by medications with anticholinergic properties in elderly patients in Australia. The study was a qualitative, prospective, observational case-control study. Interviews at baseline and six-month were performed. Medications changes were theoretically possible to reduce the Anticholinergic Cognitive Burden score, but occasionally are impractical to implement. When it was safe to implement, recommendations were in most cases dismissed by doctors. The study could not draw a clear conclusion on pharmacist ability to improve older patients’ cognitive functions as the recommendations were not tested. The home medication review process is lacking the step that obligate the referring doctor to communicate the reason for not implementing the recommendations made by the pharmacist who needs to be addressed by Medicare. This will ensure that medication use is optimised.
dc.language.iso	en
dc.publisher	International Journal of Recent Advances in Multidisciplinary Research
dc.relation.url	http://www.ijramr.com/issue/effect-medication-reviews-reducing-medication-anticholinergic-burden-elderly-patients
dc.subject	Homemedication review
dc.subject	Anticholinergic burden
dc.subject	Cognitive impairment
dc.subject	Cognitive function
dc.subject	Pharmacist clinical services
dc.title	The effect of medication reviews on reducing medication anticholinergic burden in elderly patients
dc.type	Journal article
dc.identifier.journal	International Journal of Recent Advances in Multidisciplinary Research
dc.date.accepted	2017-11-01
rioxxterms.funder	University of Wolverhampton
rioxxterms.identifier.project	UoW281117HM
rioxxterms.version	AM
rioxxterms.licenseref.uri	https://creativecommons.org/CC BY-NC-ND 4.0
rioxxterms.licenseref.startdate	2019-03-01
dc.source.volume	4
dc.source.issue	11
refterms.dateFCD	2018-10-19T09:23:24Z
refterms.versionFCD	AM
html.description.abstract	Anticholinergic side effects of medications often misdiagnosed as cognitive function decline in the elderly. The study aims to explore the effectiveness of home medication reviews on reducing anticholinergic burden caused by medications with anticholinergic properties in elderly patients in Australia. The study was a qualitative, prospective, observational case-control study. Interviews at baseline and six-month were performed. Medications changes were theoretically possible to reduce the Anticholinergic Cognitive Burden score, but occasionally are impractical to implement. When it was safe to implement, recommendations were in most cases dismissed by doctors. The study could not draw a clear conclusion on pharmacist ability to improve older patients’ cognitive functions as the recommendations were not tested. The home medication review process is lacking the step that obligate the referring doctor to communicate the reason for not implementing the recommendations made by the pharmacist who needs to be addressed by Medicare. This will ensure that medication use is optimised.